NEW YORK (GenomeWeb News) – German analytic instrument firm Analytik Jena today said that revenues for its Fiscal Year 2012 increased 9 percent year over year.

For the fiscal year ended Sept. 30, Analytik Jena posted €94.0 million ($124.4 million) in revenues, up from €86.3 million a year ago.

Analytical Instrumentation, the company's largest segment, recorded €60.0 million in revenues, up from €53.2 million a year ago, it said in a statement, while Life Science was virtually flat at €28.2 million, compared to €28.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.